DRUG
Bright Minds Biosciences Inc.
NASDAQ · Healthcare · Biotechnology · CA
$65.16
−4.20%Jul 31, 2026, 00:00 UTC
Vistagen Therapeutics appointed Douglas J. Williamson, M.D. as a director, effective July 29, 2026, with stock option compensation and eligibility for the Director Compensation Plan.